The last 15 hours of the NAD+ Mouse fundraiser and we are only $2431 away from the final goal. If we can reach our third and final stretch goal and expand the scope of the experiment massively. Could NMN be a true anti-aging drug?... https://t.co/JZXJQUDrzt
Today, we have a small update just to let you know things are progressing despite some delays and setbacks. Things have taken longer than we hoped but we are on track to do some interesting science thanks to our backers. https://t.co/pHIODV9WmJ
Today, https://t.co/AzSiXaWmPa has launched a new crowdfunding campaign on https://t.co/AzSiXaWmPa: the NAD+ Mouse Project by Dr. David Sinclair and his team at Harvard Medical School.
The Project aims to see if NAD+... https://t.co/TabarnPyV5
We are pleased to report that lobbyists have made more progress towards classifying aging as a disease. The World Health Organization (WHO) has implemented the extension code ‘Ageing-related’ (XT9T) in the latest version of the International... https://t.co/J8MxCXkrr7
Citi has produced another of its Disruptive Innovations publications, which takes a look at what it considers to be the top ten disruptive technologies. It is a sign of the changing times that anti-aging medicines are number 2 in its list. https://t.co/RJr7OhYZUS
https://t.co/AzSiXaWmPa have partnered with Future Grind to produce the Rejuvenation Roundup Podcast, hosted by Ryan O'Shea! Explore the latest in life extension and anti-aging science with a dive into a month's worth of scientific insights and new... https://t.co/tGOvAPf5wS
A new study shows that mice reprogram their gut tissues to repair injury rolling them from an aged state back to a more fetal-like one. https://t.co/MWa0H5bMxR https://t.co/HNQjFFTE4S
Australian researchers have made a discovery about telomeres that may have implications for aging, heart disease, cancer, and other age-related diseases. https://t.co/YZ3sMRNfRq https://t.co/W4LGgIRLHA
A common concern in the community is that the FDA, the EMA, and other bodies, such as WHO, do not classify aging as a disease and that this poses a problem for developing therapies that target... https://t.co/eQqdrdZnZ4
A common concern in the community is that the FDA, the EMA, and other bodies, such as WHO, do not classify aging as a disease and that this poses a problem for developing therapies that target aging. However, this is not really as…https://t.co/VZM3BLUvCU https://t.co/OhzFJIvhel
I am pleased to share a report from our first NYC conference which we recently hosted. We brought some of the leading figures in biotech research and investment for a packed day of science and aging research. https://t.co/ttJNkPtI3v https://t.co/F2zgwxbpRm
We have interviewed Dr. Peter de Keizer, a researcher who is engaged in studying senescent cells and designing therapies to destroy them in order to delay and prevent age-related diseases. Cleara Biotech is currently using his rese…https://t.co/0gXRaGTPRg https://t.co/f62yq2DWTh
Today we have a report from Open Longevity School: Summer Camp 2018, an initiative in Russia focused on developing a personal health and longevity strategy, Elena Milova went to investigate. https://t.co/GJPHqjifVH https://t.co/18xTKBvAN7
We wanted to draw your attention to a new publication by James Kirkland and his team. Kirkland is one of the pioneers of senolytics, as he demonstrated that a combination of compounds could remove senescent cells and improve health…https://t.co/V000FBjJgt https://t.co/dya1AkknHA
Researchers have manipulated the immune system to respond more aggressively to cancer according to a new study. https://t.co/XckVKRW7CX https://t.co/QACr056EJF
Lately, there has been enthusiastic interest in developing therapies to remove these problematic senescent cells, but are there potentially better ways to deal with senescent cells beyond periodically purging them with senolytic dr…https://t.co/jPTdnup9QP https://t.co/zTJ7WFMvZf
Part two of our interview with Dr. Michael Fossel who is aiming to bring telomerase therapy to humans to combat Alzheimer's disease. https://t.co/hdkijbxsCA https://t.co/hlhC9aGVxD
Today, we have part one of a two-part interview with Dr. Michael Fossel, the driving force behind Telocyte, a new company focused on telomerase therapy for various diseases, and a strong advocate of telomerase therapy to treat huma…https://t.co/p2v7xq28uf https://t.co/hLaEHwv1Nq
https://t.co/AzSiXaWmPa is proud to announce Ending Age-Related Diseases: Investment Prospects & Advances in Research, a conference to be held at Cooper Union in New York City on July 12. This one-day... https://t.co/3Ug1oeHl5T